Alkermes plc. Contract Liability (Deferred Revenue)
Alkermes plc. (ALKS) had Contract Liability (Deferred Revenue) of $0 as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2026-02-25
- 2025-12-31: Contract with Customer, Liability, Current $0.00.
- 2025-09-30: Contract with Customer, Liability, Current $0.00.
- 2025-06-30: Contract with Customer, Liability, Current $578.00K.
- 2025-03-31: Contract with Customer, Liability, Current $1.61M.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-25 |
| 2025-09-30 | $0.00 10-Q · filed 2025-10-28 |
| 2025-06-30 | $578.00K 10-Q · filed 2025-07-29 |
| 2025-03-31 | $1.61M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $1.25M 10-K · filed 2026-02-25 |
| 2024-09-30 | $2.34M 10-Q · filed 2024-10-24 |
| 2024-06-30 | $3.31M 10-Q · filed 2024-07-24 |
| 2024-03-31 | $3.34M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $2.73M 10-K · filed 2025-02-12 |
| 2023-09-30 | $3.32M 10-Q · filed 2023-10-25 |
| 2023-06-30 | $3.30M 10-Q · filed 2023-07-26 |
| 2023-03-31 | $2.19M 10-Q · filed 2023-04-26 |
| 2022-12-31 | $6.82M 10-K · filed 2024-02-21 |
| 2022-09-30 | $3.98M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $3.79M 10-Q · filed 2022-07-27 |
| 2022-03-31 | $4.92M 10-Q · filed 2022-04-27 |
| 2021-12-31 | $6.34M 10-K · filed 2023-02-16 |
| 2021-09-30 | $6.40M 10-Q · filed 2021-10-27 |
| 2021-06-30 | $6.63M 10-Q · filed 2021-07-28 |
| 2021-03-31 | $7.92M 10-Q · filed 2021-04-28 |
| 2020-12-31 | $7.51M 10-K · filed 2022-02-16 |
| 2020-09-30 | $7.15M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $7.59M 10-Q · filed 2020-07-29 |
| 2020-03-31 | $6.82M 10-Q · filed 2020-04-29 |
| 2019-12-31 | $6.77M 10-K · filed 2021-02-11 |
| 2019-09-30 | $1.80M 10-Q · filed 2019-10-23 |
| 2019-06-30 | $2.10M 10-Q · filed 2019-07-25 |
| 2019-03-31 | $2.08M 10-Q · filed 2019-04-25 |
| 2018-12-31 | $3.17M 10-K · filed 2020-02-13 |
| 2018-09-30 | $6.92M 10-Q · filed 2018-10-23 |
| 2018-06-30 | $4.93M 10-Q · filed 2018-07-26 |
| 2018-03-31 | $3.52M 10-Q · filed 2018-04-26 |
| 2017-12-31 | $1.96M 10-K · filed 2019-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |